AXA Investment Managers logo

AXA Investment Managers

Europe, Ile-de-France, France, Puteaux

Description

AXA Investment Managers is a global investment management firm that manages assets on behalf of its institutional and retail clients.

Investor Profile

AXA Investment Managers has made 39 investments, with 6 in the past 12 months and 62% as lead.

Stage Focus

  • Series A (23%)
  • Series Unknown (21%)
  • Series B (18%)
  • Private Equity (13%)
  • Series C (10%)
  • Secondary Market (5%)
  • Series D (3%)
  • Post Ipo Equity (3%)
  • Seed (3%)
  • Series E (3%)

Country Focus

  • United States (38%)
  • United Kingdom (13%)
  • France (10%)
  • Sweden (8%)
  • Spain (5%)
  • Switzerland (5%)
  • Kenya (5%)
  • Brazil (5%)
  • Mexico (3%)
  • South Africa (3%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical Device
  • Medical
  • Environmental Consulting
  • Renewable Energy
  • Financial Services
  • Software
  • Energy
  • Social Entrepreneurship
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does AXA Investment Managers frequently co-invest with?

TM
Europe, Hovedstaden, Denmark, Lynge
Co-Investments: 2
Senvest Management
North America, New York, United States, New York
Co-Investments: 2
Features Capital
North America, Vermont, United States, Norwich
Co-Investments: 2
RiverVest
North America, Missouri, United States, St Louis
Co-Investments: 2
Aphelion Capital
North America, Colorado, United States, Littleton
Co-Investments: 2
Avestria Ventures
North America, California, United States, San Francisco
Co-Investments: 3
Adjuvant Capital
North America, New York, United States, New York
Co-Investments: 2
Taisho Pharmaceutical Holdings
Asia, Tokyo, Japan, Tokyo
Co-Investments: 2
RI
Europe, Hovedstaden, Denmark, Hellerup
Co-Investments: 2
Global Health Investment Fund (GHIF)
North America, New York, United States, New York
Co-Investments: 2

Which angels does AXA Investment Managers often collaborate with?

AW
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by AXA Investment Managers?

Latour Capital

Paris, Ile-de-France, France

Latour Capital is a French Private Equity firm that combines the entrepreneurial spirit and operational knowledge.

Private EquityJan 22, 2025
Agilize

Salvador, Sao Paulo, Brazil

Agilize offers online accounting services for micro and small businesses.

AccountingFinanceFinancial Services
Series UnknownNov 29, 2024
Amount Raised: $9,000,000
Rivage Investment

Paris, Ile-de-France, France

Rivage Investment offers asset and investment management solutions for private debt and equity derivatives along with advisory solutions.

Asset ManagementConsultingFinancial Services
Private EquityJul 30, 2024
Novocuff

San Luis Obispo, California, United States

Novocuff is a medical device firm committed to improving pregnancy outcomes and lowering the risk of preterm birth.

ManufacturingMedicalMedical Device
Series AJul 17, 2024
Amount Raised: $26,000,000
Switchee

London, England, United Kingdom

Data analytics and IoT business serving large social landlords

AnalyticsConsumer ElectronicsEnergy EfficiencyInternetInternet of ThingsProperty ManagementSaaSSoftware
Series UnknownJul 10, 2024
Amount Raised: $6,395,874
Axena Health

Newton, Massachusetts, United States

Axena Health develops commercial-stage medical devices for women's pelvic health.

Health CareMedicalMedical Device
Series AJun 4, 2024
Amount Raised: $9,400,000
Biolinq

San Diego, California, United States

Biolinq develops a wearable biosensor platform that is capable of measuring blood level information.

BiotechnologyHealth CareMedical DeviceWearables
Series DApr 4, 2024
Amount Raised: $58,000,000
Iceberg Data Lab

Paris, Ile-de-France, France

Iceberg Data Lab offers financial companies with environmental data solutions to report and manage environmental impact.

AnalyticsConsultingEnvironmental ConsultingInformation TechnologySoftware
Series AApr 3, 2024
Amount Raised: $9,971,084
LimmaTech Biologics

Schlieren, Zurich, Switzerland

LimmaTech Biologics AG is a clinical stage biopharmaceutical company.

BiopharmaBiotechnology
Series AFeb 1, 2024
Amount Raised: $3,000,000
LimmaTech Biologics

Schlieren, Zurich, Switzerland

LimmaTech Biologics AG is a clinical stage biopharmaceutical company.

BiopharmaBiotechnology
Series AOct 9, 2023
Amount Raised: $36,462,275